Home » Stocks » Avid Bioservices

Avid Bioservices, Inc. (CDMO)

Stock Price: $8.20 USD 0.05 (0.61%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 464.14M
Revenue (ttm) 69.84M
Net Income (ttm) -2.57M
Shares Out 56.60M
EPS (ttm) -0.13
PE Ratio n/a
Forward PE 78.74
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 23, 2020
Last Price $8.20
Previous Close $8.15
Change ($) 0.05
Change (%) 0.61%
Day's Open 8.18
Day's Range 7.96 - 8.26
Day's Volume 139,099
52-Week Range 3.02 - 9.10

More Stats

Market Cap 464.14M
Enterprise Value 457.76M
Earnings Date (est) Dec 14, 2020
Ex-Dividend Date n/a
Shares Outstanding 56.60M
Float 56.16M
EPS (basic) -0.13
EPS (diluted) -0.13
FCF / Share 0.03
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 0.38%
Payout Ratio n/a
Shares Short 1.94M
Short Ratio 4.05
Short % of Float 3.45%
Beta 2.26
PE Ratio n/a
Forward PE 78.74
P/FCF Ratio 263.87
PS Ratio 6.65
PB Ratio 9.91
Revenue 69.84M
Operating Income -2.85M
Net Income -2.57M
Free Cash Flow 1.76M
Net Cash 6.38M
Net Cash / Share 0.11
Gross Margin 5.63%
Operating Margin -4.08%
Profit Margin -11.40%
FCF Margin 2.52%
ROA -1.50%
ROE -5.35%
ROIC -4.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(34.15% upside)
Current: $8.20
Target: 11.00
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth11.38%-0.03%-6.96%29.92%65.63%19.55%3.31%42.34%12.9%-
Gross Profit3.937.22-2.9219.3721.3911.
Operating Income-10.94-5.62-20.641.293.49-50.50-35.71-28.35-42.07-34.69
Net Income-10.47-4.22-21.81-28.16-55.65-50.36-35.36-29.78-42.12-34.15
Shares Outstanding56.3355.9847.0637.1130.9026.0823.0817.2011.948.70
Earnings Per Share-0.27-0.16-0.56-0.88-1.95-2.07-1.54-1.75-3.50-3.92
Operating Cash Flow5.83-11.60-25.99-39.17-39.59-36.02-28.25-20.93-35.88-26.46
Capital Expenditures-3.814.54-0.79-3.63-8.88-9.05-0.76-0.85-1.55-0.91
Free Cash Flow2.02-7.05-26.79-42.80-48.47-45.07-29.01-21.78-37.43-27.37
Cash & Equivalents36.6133.5043.4247.9562.0168.0077.4935.2018.0323.08
Total Debt26.85--------1.32
Net Cash / Debt9.7633.5043.4247.9562.0168.0077.4935.2018.0321.75
Book Value41.9053.0755.7453.5850.0759.0467.7023.769.4815.42
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Avid Bioservices, Inc.
Country United States
Employees 222
CEO Nicholas S. Green

Stock Information

Ticker Symbol CDMO
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: CDMO


Avid Bioservices, a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, purification, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. Avid Bioservices, Inc. has a process development and manufacturing agreement with Oragenics, Inc. to develop coronavirus vaccine. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was founded in 1981 and is headquartered in Tustin, California.